Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,368.00
Bid: 2,357.00
Ask: 2,358.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.042%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2,368.00
HLMA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update

23 Sep 2020 07:00

RNS Number : 7856Z
Halma PLC
23 September 2020
 

Halma plc

Trading update

23 September 2020

 

Halma today releases its scheduled trading update, for the period from 1 April 2020 to date, and confirmation of a management appointment to its Executive Board.

 

Halma has delivered a resilient performance during the period in line with the Board's expectations and, despite the operational challenges arising from the Covid-19 pandemic, the Group has continued to benefit from the long-term growth drivers in its markets, the breadth of its portfolio and the agility of its business model.

 

At the end of the first quarter we reported that revenue was 13% lower than last year on an organic constant currency basis. Since then, the Group's revenue trends have gradually improved, while continued control of costs and working capital have protected profit and ensured good cash generation. Order intake was ahead of revenue albeit marginally down on the same period last year. Given the evolving and uncertain situation in our major markets, the Board continues to expect Adjusted profit before tax (note 1) for FY2021 to be 5%-10% below FY2020 and more weighted to the second half than in previous years.

 

There has continued to be a significant variation in demand in individual end-markets and geographic regions. The USA and Mainland Europe regions have delivered the most resilient overall trading performances. The UK and Asia Pacific have remained more challenging, although the latter has benefited from prior year acquisitions and a gradual recovery in China.

 

The Environmental & Analysis sector has performed well, and the Medical sector has started to see a modest improvement in demand for products related to elective surgical and diagnostic procedures. The Safety sectors were impacted by limitations of physical access to sites in the first quarter, however this has steadily improved during the second quarter to date.

 

The currency translation effect on the Group's results in the first half of the year is expected to be broadly neutral.

 

The Group's financial position remains robust, with committed facilities totalling approximately £750 million at current exchange rates. The earliest maturity in these facilities is for £73 million in January 2021, with the remaining maturities from 2023 onwards. Our sector M&A teams have been actively cultivating opportunities, and the Group continues to see a healthy acquisition pipeline for the future.

 

The results for the half year ending 30 September 2020 will be released on 19 November 2020.

 

New Group General Counsel and Executive Board member

On 14th September 2020, Funmi Adegoke joined Halma as our Group General Counsel. Funmi will continue our work to maintain a strong legal and compliance capability to support the Group's growth, including oversight of our Company Secretariat activities.

 

Before joining Halma, Funmi spent nine years at BP in various roles, most recently as Managing Counsel for BP's Downstream Commercial Development and Transformation business. Prior to BP, Funmi held senior legal and commercial roles with Bombardier. Funmi is a qualified Barrister and holds a law degree from the University of Cambridge. She is a Non-Executive Director of Melrose Industries plc.

 

 

For further information, please contact:

 

Halma plc

Marc Ronchetti, Chief Financial Officer

+44 (0)1494 721111

 

MHP Communications

Rachel Hirst/ Giles Robinson

+44 (0)20 3128 8788

 

About Halma

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Our innovative products and solutions address many of the key issues facing the world today. We operate in four sectors: Process Safety, Infrastructure Safety, Medical and Environmental & Analysis. We employ over 7,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia-Pacific. We target global niche markets where sustainable growth and high returns are supported by long-term drivers. Halma is listed on the London Stock Exchange and has been a member of the FTSE 100 index since December 2017.

 

Notes

 

1. Adjusted profit before tax is before amortisation and impairment of acquired intangible assets, acquisition items, restructuring costs and profit or loss on disposal of businesses.

 

2. This Trading Update is based upon current management accounts information. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks, including the effects of the current COVID-19 outbreak.

 

3. A copy of this announcement, together with other information about Halma, may be viewed on our website www.halma.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSEEFMEESSEDU
Date   Source Headline
19th Mar 20243:53 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSTrading Update
4th Mar 20247:00 amRNSAcquisition
21st Feb 20244:17 pmRNSDirector/PDMR Shareholding
30th Jan 20247:00 amRNSDirectorate Change
30th Nov 20235:28 pmRNSPDMR Shareholding
22nd Nov 20234:36 pmRNSDirector Declaration
20th Nov 20237:00 amRNSAcquisition
16th Nov 20237:00 amRNSHalf Year Results
25th Oct 20237:00 amRNSAcquisitions
3rd Oct 202310:50 amRNSDirector/PDMR Shareholding
27th Sep 202312:28 pmRNSHolding(s) in Company
25th Sep 20231:00 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSTrading Update
4th Aug 20237:00 amRNSAcquisition
31st Jul 20233:00 pmRNSDirector/PDMR Shareholding
24th Jul 20239:00 amRNSDirectorate Change
20th Jul 20233:51 pmRNSResult of AGM
30th Jun 20239:00 amRNSDirector/PDMR Shareholding
28th Jun 20233:00 pmRNSDirector/PDMR Shareholding
22nd Jun 20233:58 pmRNSAnnual Financial Report
15th Jun 20237:00 amRNSFull Year Results
30th May 20237:11 amRNSDirector Declaration
12th May 20238:00 amRNSCompletion of acquisition
5th May 20237:00 amRNSAcquisition
28th Mar 20237:00 amRNSAcquisition
16th Mar 20237:00 amRNSTrading update
1st Mar 20233:39 pmRNSDirector/PDMR Shareholding
1st Feb 20237:00 amRNSAcquisition
12th Jan 20237:00 amRNS2022 AGM – Voting Results Update Statement
29th Nov 202212:42 pmRNSDirector/PDMR Shareholding
17th Nov 20227:00 amRNSHalf Year Results
11th Nov 20227:00 amRNSHalma appoints new Chief Financial Officer
6th Oct 20227:00 amRNSAcquisition
3rd Oct 20224:38 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSAcquisition
22nd Sep 20227:00 amRNSTrading Statement
28th Jul 20223:01 pmRNSDirector/PDMR Shareholding
21st Jul 20223:33 pmRNSResult of AGM
4th Jul 20223:38 pmRNSDirector/PDMR Shareholding
29th Jun 20229:54 amRNSDirector/PDMR Shareholding
23rd Jun 20225:50 pmRNSAnnual Financial Report
17th Jun 20224:41 pmRNSDirector/PDMR Shareholding
16th Jun 20227:01 amRNSGroup Chief Executive succession
16th Jun 20227:00 amRNSFinal Results
14th Apr 20227:00 amRNSAcquisition
7th Apr 20227:00 amRNSSite Visit
28th Mar 20221:59 pmRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSTrading update
21st Feb 20227:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.